Publications by authors named "Patrick Urban"

Claim this Profile
I
Ianalumab plus Eltrombopag in Immune Thrombocytopenia.
Adam Cuker, Thomas Stauch, Nichola Cooper, Hanny Al-Samkari, Marc Michel, Patrick Urban

N Engl J Med· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Eltrombopag in combination with immunosuppressive therapy in pediatric severe aplastic anemia: phase 2 ESCALATE trial.
Akiko Shimamura, Alexey Maschan, Carolyn Bennett, Sujith Samarasinghe, Jason E Farrar, Patrick Urban

Blood Adv· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Photolipid Bilayer Permeability is Controlled by Transient Pore Formation.
Stefanie D Pritzl, Patrick Urban, Alexander Prasselsperger, David B Konrad, James A Frank

Langmuir· November 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Lipid Photoswitch Controls Fluidity in Supported Bilayer Membranes.
Patrick Urban, Stefanie D Pritzl, Martina F Ober, Christina F Dirscherl, Carla Pernpeintner

Langmuir· March 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Application of time-dependent modeling for the exposure-efficacy analysis of ceritinib in untreated ALK-rearranged advanced NSCLC patients.
Yvonne Y Lau, Wen Gu, Yu-Yun Ho, Ying Hong, Xinrui Zhang, Patrick Urban

Cancer Chemother Pharmacol· September 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Light-Controlled Lipid Interaction and Membrane Organization in Photolipid Bilayer Vesicles.
Patrick Urban, Stefanie D Pritzl, David B Konrad, James A Frank, Carla Pernpeintner

Langmuir· November 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Neoadjuvant buparlisib plus trastuzumab and paclitaxel for women with HER2+ primary breast cancer: A randomised, double-blind, placebo-controlled phase II trial (NeoPHOEBE).
Sibylle Loibl, Lorena de la Pena, Valentina Nekljudova, Dimitrios Zardavas, Stefan Michiels, Patrick Urban

Eur J Cancer· November 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effect of nitrogen atom positioning on the trade-off between emissive and photocatalytic properties of carbon dots.
Santanu Bhattacharyya, Florian Ehrat, Patrick Urban, Roland Teves, Regina Wyrwich, Alexander S Urban

Nat Commun· November 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Buparlisib plus fulvestrant versus placebo plus fulvestrant in postmenopausal, hormone receptor-positive, HER2-negative, advanced breast cancer (BELLE-2): a randomised, double-blind, placebo-controlled, phase 3 trial.
José Baselga, Seock-Ah Im, Hiroji Iwata, Javier Cortés, Michele De Laurentiis, Patrick Urban

Lancet Oncol· July 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Ceritinib versus chemotherapy in patients with ALK-rearranged non-small-cell lung cancer previously given chemotherapy and crizotinib (ASCEND-5): a randomised, controlled, open-label, phase 3 trial.
Alice T Shaw, Tae Min Kim, Lucio Crinò, Cesare Gridelli, Katsuyuki Kiura, Patrick Urban

Lancet Oncol· July 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Light-Controlled Membrane Mechanics and Shape Transitions of Photoswitchable Lipid Vesicles.
Carla Pernpeintner, James A Frank, Patrick Urban, Christian R Roeske, Stefanie D Pritzl

Langmuir· April 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
Q
Quantitative Single-Molecule Surface-Enhanced Raman Scattering by Optothermal Tuning of DNA Origami-Assembled Plasmonic Nanoantennas.
Sabrina Simoncelli, Eva-Maria Roller, Patrick Urban, Robert Schreiber, Andrew J Turberfield

ACS Nano· November 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Reversible control of current across lipid membranes by local heating.
Patrick Urban, Silke R Kirchner, Christian Mühlbauer, Theobald Lohmüller, Jochen Feldmann

Sci Rep· March 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
PI3K inhibitors as new cancer therapeutics: implications for clinical trial design.
Cristian Massacesi, Emmanuelle Di Tomaso, Patrick Urban, Caroline Germa, Cornelia Quadt

Onco Targets Ther· January 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Multicenter phase 2 study of patupilone for recurrent or progressive brain metastases from non-small cell lung cancer.
Lakshmi Nayak, Lisa M DeAngelis, H Ian Robins, Ramaswamy Govindan, Shirish Gadgeel, Patrick Urban

Cancer· December 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Metabolism of patupilone in patients with advanced solid tumor malignancies.
Kevin R Kelly, Markus Zollinger, Frédéric Lozac'h, Eugene Tan, Alain Mita, Patrick Urban

Invest New Drugs· June 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pharmacokinetics and antitumor activity of patupilone combined with midazolam or omeprazole in patients with advanced cancer.
Apostolia-Maria Tsimberidou, Nancy Lewis, Tony Reid, Howard Burris, Patrick Urban

Cancer Chemother Pharmacol· December 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effects of patupilone on the pharmacokinetics and pharmacodynamics of warfarin in patients with advanced malignancies: a phase I clinical trial.
Apostolia-Maria Tsimberidou, Chris H M Takimoto, Stacy Moulder, Cynthia Uehara, Monica Mita, Patrick Urban

Mol Cancer Ther· January 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Low E2F1 transcript levels are a strong determinant of favorable breast cancer outcome.
Vincent Vuaroqueaux, Patrick Urban, Martin Labuhn, Mauro Delorenzi, Pratyaksha Wirapati

Breast Cancer Res· September 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparison of gene expression profiles in core biopsies and corresponding surgical breast cancer samples.
Rosanna Zanetti-Dällenbach, Vincent Vuaroqueaux, Edward Wight, Martin Labuhn, Gad Singer, Patrick Urban

Breast Cancer Res· January 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Increased expression of urokinase-type plasminogen activator mRNA determines adverse prognosis in ErbB2-positive primary breast cancer.
Patrick Urban, Vincent Vuaroqueaux, Martin Labuhn, Mauro Delorenzi, Pratyaksha Wirapati

J Clin Oncol· September 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phosphorylation of tyrosine 1248-ERBB2 measured by chemiluminescence-linked immunoassay is an independent predictor of poor prognosis in primary breast cancer patients.
Jonas Cicenas, Patrick Urban, Willy Küng, Vincent Vuaroqueaux, Martin Labuhn

Eur J Cancer· March 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Increased level of phosphorylated akt measured by chemiluminescence-linked immunosorbent assay is a predictor of poor prognosis in primary breast cancer overexpressing ErbB-2.
Jonas Cicenas, Patrick Urban, Vincent Vuaroqueaux, Martin Labuhn, Willy Küng

Breast Cancer Res· January 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis